Names | |
---|---|
IUPAC name
(3S)-3-Hydroxy-2,3-dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one
|
|
Identifiers | |
486-64-6 | |
3D model (Jmol) | Interactive image |
ChEBI | CHEBI:9936 |
ChEMBL | ChEMBL3120244 |
ChemSpider | 391238 |
ECHA InfoCard | 100.208.620 |
PubChem | 442935 |
UNII | G6T5819NXM |
|
|
|
|
Properties | |
C11H10N2O2 | |
Molar mass | 202.21 g·mol−1 |
Density | 1.5 g/cm3 |
Melting point | 200 to 202 °C (392 to 396 °F; 473 to 475 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Vasicinone is a quinazoline alkaloid. It shows bronchodilatory activity in vitro but bronchoconstrictory activity in vivo. Vasicinone was shown to have an antianaphylactic action.
Vasicinone has also been studied in combination with the related alkaloid vasicine. Both the alkaloids in combination (1:1) showed pronounced bronchodilatory activity in vivo and in vitro. Both alkaloids are also respiratory stimulants. Vasicine has a cardiac–depressant effect, while vasicinone is a weak cardiac stimulant; the effect can be normalized by combining the alkaloids. Vasicine is reported to have a uterine stimulant effect.